High Burden of Premature Arteriosclerosis on Renal Biopsy Results in Incident Lupus Nephritis
| Autor: | Shivani Garg, Michael G. Semanik, Yabing Huang, Christie M. Bartels, Weixiong Zhong, Sarah E. Panzer, Karen E. Hansen, Maureen A. Smith |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Biopsy Lupus nephritis Disease Gastroenterology Risk Assessment Article 03 medical and health sciences Young Adult 0302 clinical medicine Renal Artery Wisconsin Rheumatology Risk Factors Internal medicine medicine Prevalence Humans Age of Onset Child Grading (tumors) Aged 030203 arthritis & rheumatology Kidney medicine.diagnostic_test business.industry Incidence Glomerulonephritis Arteriosclerosis Middle Aged medicine.disease Atherosclerosis Lupus Nephritis medicine.anatomical_structure Case-Control Studies Child Preschool Female Renal biopsy business |
| Zdroj: | Arthritis Care Res (Hoboken) |
| Popis: | Objective Cardiovascular disease (CVD) is accelerated in patients with systemic lupus erythematosus and lupus nephritis (LN). Despite the literature suggesting that renal arteriosclerosis predicts CVD in other glomerulonephritis diseases, arteriosclerosis grading and reporting might be particularly overlooked in LN biopsies. Our objective was to examine the burden of renal arteriosclerosis in LN and to assess whether arteriosclerosis is underreported in LN biopsies. Methods We identified all patients with LN undergoing kidney biopsy between 1994 and 2017 at an academic center. We interpreted LN biopsy reports to classify the Banff categories of absent, mild, moderate, or severe renal arteriosclerosis. The prevalence of renal arteriosclerosis was compared with the prevalence published for age-matched healthy peers, and predictors of arteriosclerosis were examined. We overread biopsies for Banff renal arteriosclerosis grading and compared to pathology reports. Results Among 189 incident patients with LN, renal arteriosclerosis prevalence was 2 decades earlier compared to their healthy peers, affecting 40% of patients ages 31-39 years with LN compared to 44% of healthy peers ages 50-59 years. A multivariable analysis showed a 3-fold higher odds of renal arteriosclerosis in patients ages ≥30 years with LN. LN chronicity on biopsy results predicted a 4-fold higher odds of renal arteriosclerosis. The overreads determined that 50% of standard LN biopsy reports missed reporting the presence or absence of renal arteriosclerosis. Conclusion Renal arteriosclerosis is accelerated by 2 decades in patients with LN compared to their healthy peers and is overlooked by pathologists in half of the routine biopsy reports. We propose incorporating Banff renal arteriosclerosis grading in all LN biopsy reports. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|